New shot offers hope for kids battling tough leukemia
NCT ID NCT07134088
Summary
This study is testing a new, under-the-skin injection of a drug called blinatumomab in children under 12 years old with a type of blood cancer called B-cell acute lymphoblastic leukemia (B-ALL) that has come back or hasn't responded to other treatments. The main goals are to see if this injection method is safe and if it can help put the cancer into remission. The study will also look at how the drug moves through the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED/REFRACTORY B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Kanagawa Childrens Medical Center
RECRUITINGYokohami-shi, Kanagawa, 232-8555, Japan
-
Seattle Childrens Hospital
RECRUITINGSeattle, Washington, 98105, United States
-
St Jude Childrens Research Hospital
RECRUITINGMemphis, Tennessee, 38105, United States
Conditions
Explore the condition pages connected to this study.